Although, it has long been accepted that both IBD and IBS susceptibility lies primarily in the domain of immune regulation, or epithelial integrity, only recently it became increasingly clear that neuro–immune interactions, via the participation of CRH or other neuropeptides, can substantially influence the intestinal functions and the immune responses in the GI tract. The gene discussed is CRH; the disease is inflammatory bowel disease.